Citi Pharma Limited (CPHL), a Pakistani pharmaceutical company, has decided to venture into the real estate sector with the ...

The results of the ONWARDS 2 trial of insulin icodec showed that it was as effective as daily dosing with Novo Nordisk's Tresiba (insulin degludec) once per day at controlling blood glucose ...

The approval covers all 27 European Union member states. Tresiba (insulin degludec) is a once-daily new-generation based insulin analogue with an ultra-long duration of action. Ryzodeg (insulin ...

Inhaled technosphere insulin (TI) plus insulin degludec is noninferior to usual care among patients with type 1 diabetes (T1D), according to findings published in Diabetes Care. Inhaled TI is a ...

The INHALE-3 trial (2024) compared the efficacy of an inhaled insulin regimen (Afrezza) plus long acting degludec insulin against usual care over 17 weeks among 123 adults. More participants using the ...

T1DM, Type 1 Diabetes Mellitus; DKA, Diabetic Ketoacidosis. Following successful glycemic control, the patient was discharged with a regimen of 12 U of degludec insulin for subcutaneous injection at ...

The Inflation Reduction Act (IRA), passed in 2022, made changes to the way drugs are covered and reimbursed in Medicare.

A new study shows that semaglutide can improve glucose levels for people with type 1 diabetes who use automated pumps, without increasing hypoglycemia. In this double-blinded randomized trial ...

Objective Many societies recommend using estimated glomerular filtration rate (eGFR) rather than serum creatinine (sCr) to determine metformin eligibility. We examined the potential impact of ...

Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

Pharmacokinetics is an area of pharmacology concerned with the time course of absorption, distribution, metabolism and excretion (collectively ADME) of drugs from biological systems in order to ...